Bellicum Pharmaceuticals (BLCM) Institutional Ownership → Urgent Nvidia Warning (From Altimetry) (Ad) Free BLCM Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share OwnershipStock AnalysisEarningsOwnershipSocial MediaStock AnalysisEarningsOwnershipSocial Media Institutional Ownership Changes (13F Filings) for Bellicum Pharmaceuticals (NASDAQ:BLCM)CurrentInstitutional OwnershipPercentage4.93%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$166.50KNumber ofInstitutional Sellers(last 12 months)0 Get BLCM Insider Trade Alerts Want to know when executives and insiders are buying or selling Bellicum Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BLCM Institutional Buying and Selling by Quarter Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Bellicum Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2023Boxer Capital LLC450,000$167K0.0%N/A4.737% 2/14/2023Susquehanna International Group LLP42,310$30K0.0%+42.5%0.491% 8/16/2021Squarepoint Ops LLC16,327$54K0.0%-41.5%0.194% 8/16/2021State Street Corp27,245$90K0.0%N/A0.324% 8/13/2021LPL Financial LLC29,458$97K0.0%+76.4%0.351% 8/13/2021Geode Capital Management LLC58,659$193K0.0%+86.8%0.698% Get the Latest News and Ratings for BLCM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bellicum Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/13/2021Vanguard Group Inc.424,311$1.40M0.0%+111.3%5.053% 5/21/2021Citadel Advisors LLC54,047$203K0.0%+100.4%0.644% 5/18/2021Citadel Advisors LLC54,047$203K0.0%+100.4%0.650% 5/13/2021 Bank of New York Mellon Corp13,308$50K0.0%N/A0.160% 5/11/2021Acadian Asset Management LLC32,595$123K0.0%N/A0.392% 2/16/2021Squarepoint Ops LLC26,044$92K0.0%N/A0.515% 2/12/2021Ikarian Capital LLC500,000$1.77M0.1%N/A9.881% 2/10/2021Renaissance Technologies LLC26,631$94K0.0%-83.3%0.526% 2/9/2021Wells Fargo & Company MN12,787$45K0.0%-50.0%0.253% 2/4/2021GSA Capital Partners LLP66,558$235K0.0%N/A1.315% 9/4/2020 Principal Financial Group Inc.53,238$396K0.0%N/A1.052% 8/31/2020Bridgeway Capital Management Inc.29,180$217K0.0%N/A0.577% 7/31/2020UBS Group AG10,369$77K0.0%+25.3%0.205% 5/19/2020X Square Capital LLC22,374$105K0.1%-88.8%0.443% 5/15/2020Sabby Management LLC18,927$89K0.0%N/A0.375% 5/15/2020Tower Research Capital LLC TRC12,917$61K0.0%+58.1%0.256% 5/15/2020Morgan Stanley24,725$116K0.0%-59.1%0.490% 5/14/2020Wells Fargo & Company MN24,575$116K0.0%-91.3%0.487% 5/14/2020Tekla Capital Management LLC6,000$28K0.0%-90.0%0.119% 5/13/2020Frazier Management LLC105,144$495K0.1%-90.0%2.082% 5/4/2020Nikko Asset Management Americas Inc.217,696$1.03M0.0%-90.5%4.311% 5/1/2020BlackRock Inc.100,773$474K0.0%-90.0%1.996% 5/1/2020UBS Group AG8,275$39K0.0%-80.9%0.164% 4/27/2020 Sumitomo Mitsui Trust Holdings Inc.217,696$1.03M0.0%-90.5%4.311% 2/20/2020Geode Capital Management LLC416,449$537K0.0%+18.1%8.346% 2/14/2020UBS Group AG43,417$56K0.0%+18.9%0.870% (Data available from 1/1/2016 forward) BLCM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BLCM shares? During the previous two years, the following institutional investors and hedge funds held shares of Bellicum Pharmaceuticals shares: Boxer Capital LLC ($167K), Susquehanna International Group LLP ($30K).Learn more on BLCM's institutional investors. What percentage of Bellicum Pharmaceuticals stock is owned by institutional investors? 4.93% of Bellicum Pharmaceuticals stock is owned by institutional investors. Learn more on BLCM's institutional investor holdings. Which institutional investors have been buying Bellicum Pharmaceuticals stock? The following institutional investors have purchased Bellicum Pharmaceuticals stock in the last 24 months: Boxer Capital LLC ($450K), and Susquehanna International Group LLP ($12.62K). How much institutional buying is happening at Bellicum Pharmaceuticals? Institutional investors have bought a total of 462,616 shares in the last 24 months. This purchase volume represents approximately $175.58K in transactions. Related Companies: Eiger BioPharmaceuticals Institutional Ownership Bellerophon Therapeutics Institutional Ownership Evelo Biosciences Institutional Ownership Acorda Therapeutics Institutional Ownership Invitae Institutional Ownership Aditxt Institutional Ownership Allarity Therapeutics Institutional Ownership Virax Biolabs Group Institutional Ownership TC Biopharm Institutional Ownership Motus GI Institutional Ownership This page (NASDAQ:BLCM) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCould Your Accounts Be Frozen?Allegiance GoldFW: 234x GainWeiss RatingsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellicum Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
